Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Collagen-based Scaffold Supports Tendon-to-bone Healing After Rotator Cuff Repair: An Integrated Translational Study.

Advanced healthcare materials·2026
Same author

Evaluating the Effects of Poly(ε-Caprolactone)-Nanohydroxyapatite Composition on 3D-Printed Scaffold Structural Properties.

Journal of biomedical materials research. Part A·2026
Same author

Topographical design principles for osteochondral tissue engineering.

Bioactive materials·2026
Same author

Comparison of innovative medical devices between China and the United States.

Regenerative biomaterials·2026
Same author

Bone matrix-inspired whitlockite porous ceramic with effects of autophagy activation contributes to bone regeneration.

Bioactive materials·2026
Same author

3D Printing Colloidal Gels: Navigating the Printability Barrier.

Tissue engineering. Part C, Methods·2025

Related Experiment Video

Updated: Apr 26, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K

3D tissue-engineered model of Ewing's sarcoma.

Salah-Eddine Lamhamedi-Cherradi1, Marco Santoro2, Vandhana Ramammoorthy1

  • 1Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center (MDACC), Houston, TX 77054, USA.

Advanced Drug Delivery Reviews
|August 12, 2014
PubMed
Summary

Three-dimensional (3D) models are crucial for studying Ewing

Keywords:
3DECMEwing's sarcomaMCTSPreclinical testingScaffoldsTissue-engineeringTumor model

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

9.5K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

11.9K

Related Experiment Videos

Last Updated: Apr 26, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

9.5K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

11.9K

Area of Science:

  • Oncology
  • Biomaterials Science
  • Cancer Biology

Background:

  • Monolayer cell cultures are standard for cancer research but fail to replicate complex tumor microenvironments.
  • Ewing's sarcoma (ES), a pediatric bone tumor, exhibits hallmarks that are poorly represented in 2D models.
  • Advancements in targeted therapies necessitate preclinical models that mimic tumor-extracellular matrix interactions.

Purpose of the Study:

  • To review and highlight innovative methods for fabricating biomimetic three-dimensional (3D) models of Ewing's sarcoma (ES).
  • To discuss the importance of 3D models in understanding ES oncogenesis, maintenance, and spread.
  • To explore the application of these models in preclinical drug testing and personalized medicine for ES.

Main Methods:

  • Fabrication of biomimetic 3D ES tumor models.
  • Incorporation of cellular milieu and extracellular matrix (ECM) components.
  • Review of innovative biomaterial and tissue engineering techniques.

Main Results:

  • 3D models effectively mimic critical hallmarks of ES oncogenesis and progression.
  • Biomimetic models allow for more accurate assessment of antineoplastic effects.
  • These models facilitate the study of drug resistance mechanisms in a clinically relevant context.

Conclusions:

  • Advanced 3D culture systems are essential for accurate Ewing's sarcoma research.
  • Biomimetic ES models offer improved platforms for drug screening and personalized therapeutic strategies.
  • Future research should leverage 3D models to enhance understanding and treatment of pediatric bone tumors.